Goat Anti-FHL1 / SLIM1, Biotinylated Antibody

Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.

100 µg

Aliquot and store at -20°C. Minimize freezing and thawing.

RP11-535K18.1|MGC111107|KYO-T|Four-and-a-half LIM domains 1| Isl-1 and Mec-3 domains 1|skeletal muscle LIM-protein 1|four-and-a-half Lin11|LIM protein SLIMMER|XMPMA|SLIMMER|SLIM1|SLIM-1|SLIM|KYOT|FLH1A|FHL1B|FHL1A|FHL-1|four and a half LIM domains 1|FHL1

NP_001440.2; NP_001153171.1

EBP06507-B

Peptide with sequence CNKRFVFHNEQVY., from the internal region of the protein sequence according to NP_001440.2; NP_001153171.1.

This antibody is expected to recognise isoforms 2 (NP_001440.1) and 5 (NP_001153171.1). Since June 2009 the second N residue in the immunizing peptide is no longer representative as it has been substituted by Q at position 284 of NP_001440.2. Variants NP_001440.2, NP_001153176.1 and NP_001153172.1 represent identical protein.

CNKRFVFHNEQVY.

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Refrigerated

Human, Mouse, Rat, Dog, Pig, Cow

Human, Mouse

2273

14199

25177

Antibody detection limit dilution 1:16000.

Approx 30kDa band observed in Human Heart lysates (calculated MW of 31.9kDa according to NP_001440.2). See non-biotinylated parental product's datasheet for further QC data. Recommended concentration: 0.3-1µg/ml.

Pep-ELISA, WB, IHC